Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
13 天
MarketBeat on MSNAI Pharma: 2 Paths to AI-Powered Drug InvestmentThe pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...
Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine ...
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...
It’s no secret that drug development is a huge gamble for pharmaceutical companies. The process involves betting billions of dollars and more than a decade of time that a compound will beat the ...
The pharmaceutical industry is at a pivotal ... Besides speeding up the drug development process significantly, these technologies are allowing for better predictions of protein structures.
Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果